CenterBook Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

CenterBook Partners’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7,177	Closed	-$525K	–	613
2024 Q3	$525K	Sell	7,177 -8,491	-54%	-$638K	0.03%	380
2024 Q2	$1.07M	Buy	+15,668	New	+$1.09M	0.07%	327
2023 Q2	–	Sell	-16,029	Closed	-$868K	–	501
2023 Q1	$868K	Buy	+16,029	New	+$775K	0.12%	254
2022 Q4	–	Sell	-6,701	Closed	-$312K	–	473
2022 Q3	$312K	Buy	+6,701	New	+$350K	0.06%	332

Other funds holding ITCI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CenterBook Partners's ITCI Position: Q4 2024 in Review

CenterBook Partners sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2024, closing a stake of 7,177 shares — an estimated $525K sold.

CenterBook Partners first reported a position in ITCI in Q3 2022 and held it in 4 quarters. The position peaked at $1.07M in Q2 2024. 387 funds tracked by Wall St. Rank hold ITCI as of Q4 2024.

CenterBook Partners reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2024 after selling out during the quarter.
CenterBook Partners sold 7,177 Intra-Cellular Therapies Inc. shares in Q4 2024, an estimated $525K.
CenterBook Partners first reported a position in Intra-Cellular Therapies Inc. in Q3 2022 and held it in 4 quarters.
CenterBook Partners's Intra-Cellular Therapies Inc. position peaked at $1.07M in Q2 2024.
387 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2024.

Based on CenterBook Partners's 13F filing for Q4 2024, filed 13 Feb 2025.